Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Donald Covington

Surgery Jacksonville, FL Medical Doctor

NPI 1427058130 CMS profile 64920

1 Shircliff Way, Jacksonville, FL 32204

Open in the dashboard

General payments

$52,182

85 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Donald Covington of Jacksonville, FL is reported in the CMS Open Payments database as having received $52,182 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,146 16
2024 General $1,826 10
2023 General $1,389 14
2022 General $312 9
2021 General $974 8
2020 General $15,866 15
2019 General $28,667 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Donald Covington
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Donald Covington were reported at $3,146. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Donald Covington Surgery median Middle half National median
2019 $28,667 $253 $82–$1,521 $163
2020 $15,866 $131 $40–$706 $114
2021 $974 $168 $50–$904 $132
2022 $312 $224 $76–$1,218 $149
2023 $1,389 $253 $82–$1,255 $160
2024 $1,826 $279 $90–$1,381 $164
2025 $3,146 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Wound Management Technologies, Inc $28,494 11 payments
  2. Sanara MedTech Inc. $13,499 10 payments
  3. Integra LifeSciences Corporation $3,877 18 payments
  4. Patriot Medical Distributors $2,275 1 payment
  5. Kerecis Limited $1,351 6 payments
  6. Alphatec Spine, Inc $1,250 1 payment
  7. TissueTech, Inc. $396 6 payments
  8. Reprise Biomedical, Inc. $249 2 payments
  9. AbbVie, Inc. $155 6 payments
  10. Biocomposites Inc $109 1 payment
  11. Other $527 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $37,692 3 payments
  2. Travel and Lodging $6,779 13 payments
  3. Food and Beverage $5,469 65 payments
  4. Long term medical supply or device loan $2,241 4 payments
Products named General payments · program years 2019–2025
  1. CellerateRx $41,993 21 payments
  2. Integra Recon-Skin And Wound $2,287 16 payments
  3. Integra Recon-Skin And Wound $1,635 14 payments
  4. Integra Recon-Skin And Wound $1,635 14 payments
  5. INTEGRA DERMAL REGENERATION TEMPLATE $1,635 14 payments
  6. PRIMATRIX $1,635 14 payments
  7. AMNIOEXCEL PLUS $1,502 1 payment
  8. Other - Miscellaneous $1,250 1 payment
  9. Kerecis Omega3 Wound $869 1 payment
  10. Kerecis Omega3 Surgibind $869 1 payment
  11. Other $4,899 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

82

Median for General Surgery: 59

Drug cost

$462

Median for General Surgery: $393

Branded share of claims

19.5%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 25 $216
Triamcinolone Acetonide Generic 17 $90
Levofloxacin Generic 12 $67
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 16 $58
Tramadol Hcl Generic 12 $31

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$91,356

Medicare's payments for the services billed

Medicare patients

193

Average age 76

Services billed

1,341

106 women, 87 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Ischemic heart disease 54%
Chronic kidney disease 53%
Diabetes 49%
Depression 44%
Atrial fibrillation 40%
Heart failure 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record